Vitamin K Deficiency Bleeding
Vitamin K is a substance that our body needs to form clots and to stop bleeding.
www.cdc.govHere are the latest commonly cited developments on vitamin K deficiency, focusing on newborn VKDB and ongoing awareness.
-
Late-onset vitamin K deficiency bleeding (VKDB) in newborns remains a concern where intramuscular vitamin K prophylaxis slightly lowers risk compared with oral regimens, especially for exclusively breastfed infants. Health bodies continue to emphasize routine intramuscular vitamin K at birth as the most effective preventive measure.[1][2]
-
Several reviews and case reports highlight that when vaccination or prophylaxis is refused or incomplete, late-onset VKDB can present with multi-system involvement, requiring urgent parenteral vitamin K and, in severe cases, plasma products or prothrombin complex concentrates.[1]
-
Guidelines across major health systems (e.g., NICE, WHO, and pediatric associations) generally prefer a single intramuscular dose of vitamin K at birth for all newborns, with oral regimens as a secondary option if IM administration is refused, though oral regimens may be less consistently protective against late VKDB.[2]
-
Recent diagnostic and treatment reviews reiterate VKD as a coagulopathy that can occur at any age but is particularly critical in infants; management centers on restoring vitamin K–dependent gamma-carboxylation of coagulation factors and supporting hemostasis if bleeding occurs.[6][9]
-
Public health reporting and media coverage in 2024–2025 highlighted cases where missed vitamin K prophylaxis contributed to adverse outcomes, underscoring the importance of adherence to birth prophylaxis guidelines and clinician-patient education around vitamin K’s role in coagulation.[3]
Illustration (example of care pathway):
- Birth: universal vitamin K prophylaxis (prefer IM 1 mg at birth).
- If IM is declined: document informed consent and use a recommended oral regimen with appropriate dosing and schedule.
- If VKDB suspected: rapidly administer parenteral vitamin K and provide advanced supportive care (e.g., fresh frozen plasma or prothrombin complex concentrates for severe cases).
If you’d like, I can pull the most recent guideline excerpts from NICE, CDC, and major pediatric societies, or summarize a specific recent clinical study with its key findings. Please tell me your preferred region or guideline source.
Citations:
- VKDB prophylaxis and IM vs oral considerations[2][1]
- Guidelines and education on vitamin K administration at birth[2]
- VKDB case/bleeding management and treatment references[9][6]
- Public-health reports and media on prophylaxis adherence issues[3]